IL131216A - Drugs inhibiting progress of pterygium and postoperative recurrence of the same - Google Patents

Drugs inhibiting progress of pterygium and postoperative recurrence of the same

Info

Publication number
IL131216A
IL131216A IL13121698A IL13121698A IL131216A IL 131216 A IL131216 A IL 131216A IL 13121698 A IL13121698 A IL 13121698A IL 13121698 A IL13121698 A IL 13121698A IL 131216 A IL131216 A IL 131216A
Authority
IL
Israel
Prior art keywords
pterygium
same
postoperative recurrence
drugs inhibiting
inhibiting progress
Prior art date
Application number
IL13121698A
Other languages
English (en)
Other versions
IL131216A0 (en
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of IL131216A0 publication Critical patent/IL131216A0/xx
Publication of IL131216A publication Critical patent/IL131216A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13121698A 1997-02-14 1998-02-13 Drugs inhibiting progress of pterygium and postoperative recurrence of the same IL131216A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6888297 1997-02-14
PCT/JP1998/000582 WO1998035668A1 (fr) 1997-02-14 1998-02-13 Medicaments entravant l'evolution du pterygion et sa recurrence postoperatoire

Publications (2)

Publication Number Publication Date
IL131216A0 IL131216A0 (en) 2001-01-28
IL131216A true IL131216A (en) 2003-10-31

Family

ID=13386482

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13121698A IL131216A (en) 1997-02-14 1998-02-13 Drugs inhibiting progress of pterygium and postoperative recurrence of the same

Country Status (11)

Country Link
US (1) US6114383A (fr)
EP (1) EP0974352B1 (fr)
CN (1) CN1118279C (fr)
AT (1) ATE240098T1 (fr)
AU (1) AU739271B2 (fr)
BR (1) BR9807330A (fr)
CA (1) CA2278421A1 (fr)
DE (1) DE69814612T2 (fr)
ES (1) ES2198692T3 (fr)
IL (1) IL131216A (fr)
WO (1) WO1998035668A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL132391A0 (en) * 1997-04-18 2001-03-19 Kissei Pharmaceutical Preventives or remedies for diseases effecting excessive proliferation or retinal pigment eptihelial cells
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
JP4966019B2 (ja) * 2005-01-06 2012-07-04 キッセイ薬品工業株式会社 慢性移植片対宿主症におけるドライアイの予防および治療剤
EP2056805B1 (fr) * 2006-08-16 2011-05-25 Action Medicines, S.L. Utilisation de dérivés de 2,5-dihydroxybenzène pour le traitement de maladies de réaction tissulaire
RU2438631C1 (ru) * 2010-06-30 2012-01-10 Учреждение Российской академии медицинских наук Научно-исследовательский институт глазных болезней РАМН (НИИГБ РАМН) Способ консервативного лечения птеригиума
AU2011334592C1 (en) 2010-11-24 2015-04-02 Occurx Pty Ltd Methods of treating eye diseases associated with inflammation and vascular proliferation
US9525195B2 (en) * 2013-07-30 2016-12-20 Johnson Controls Technology Corporation Remanufacturing methods for battery module
CN108135737B (zh) 2015-06-06 2021-11-05 拨云生物医药科技(广州)有限公司 用于治疗翼状胬肉的组合物和方法
BR112018074450A2 (pt) 2016-06-02 2019-03-19 Cloudbreak Therapeutics, Llc composições e métodos para a utilização de nintedanib para melhorar o sucesso da cirurgia do glaucoma
RU2646125C1 (ru) * 2016-09-20 2018-03-01 Константин Николаевич Руссков Способ профилактики рецидива птеригиума
EP3577103A1 (fr) 2017-02-03 2019-12-11 Certa Therapeutics Pty Ltd. Composés anti-fibrotiques
RU2653814C1 (ru) * 2017-06-01 2018-05-14 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ профилактики рецидивов птеригиума после хирургического лечения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07116029B2 (ja) * 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
JPH09176003A (ja) * 1995-12-28 1997-07-08 Tsumura & Co 角膜治療剤

Also Published As

Publication number Publication date
DE69814612D1 (de) 2003-06-18
AU739271B2 (en) 2001-10-11
CN1118279C (zh) 2003-08-20
DE69814612T2 (de) 2004-03-11
CN1247469A (zh) 2000-03-15
EP0974352A1 (fr) 2000-01-26
WO1998035668A1 (fr) 1998-08-20
ATE240098T1 (de) 2003-05-15
AU5879798A (en) 1998-09-08
EP0974352B1 (fr) 2003-05-14
BR9807330A (pt) 2000-04-18
EP0974352A4 (fr) 2001-06-06
IL131216A0 (en) 2001-01-28
US6114383A (en) 2000-09-05
ES2198692T3 (es) 2004-02-01
CA2278421A1 (fr) 1998-08-20

Similar Documents

Publication Publication Date Title
IL100015A0 (en) Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
DE69604714D1 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
GEP20033025B (en) 4,4-Biarylpiperidine Derivatives with Opioid Receptor Activity
MY133473A (en) Haterocyclic glycyl beta-alanine derivatives.
MXPA04002167A (es) Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
FI950309A0 (fi) Proliiniamidijohdannaisia
DE69531502D1 (de) Monoamid, diamid, thiol enthaltende metall-chelatierende verbindungen
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
DK0889875T3 (da) Cycloproylalkansyrederivater
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
ATE321543T1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
AU2232288A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamides
EP0391002A3 (fr) Compositions pharmaceutiques contenant de l'acide anthranilique N-(3-4-diméthoxycinnamoyl)
DE60025848D1 (en) Pyrimidin-derivate als selective inhibitoren von cox-2
IL131216A0 (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
IL148874A0 (en) Sulfonyl amino acid derivatives, their preparation and pharmaceutical compositions containing them
CA2219359A1 (fr) Derives hydantoine utilises comme produits intermediaires pour principes actifs pharmaceutiques
EP0952159A3 (fr) Utilisation des dérivés de somatostatine et/ou des dérivés de phénylhydrazone en tant qu'agents anti-inflammatoires ou analgésiques
DE69218816D1 (de) N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
CA2262791A1 (fr) Antifongiques azole contenant un ester d'acide amine
WO2001005386A3 (fr) Composition pharmaceutique utile dans le traitement de bourdonnement d'oreilles et de surdite
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees